Health-related quality of life in patients with bronchiolitis obliterans

Emine Atag1, Nilay Bas Ikizoglu2, Pinar Ergenekon2

  • 1Division of Pediatric Pulmonology, Faculty of Medicine, Medipol University, Istanbul, Turkey.

Pediatric Pulmonology
|June 10, 2020
PubMed

Insights

Children with bronchiolitis obliterans (BO) have lower health-related quality of life (HRQOL) than healthy peers. Post-hematopoietic stem cell transplantation (HSCT) BO significantly impacts HRQOL more than post-infectious causes.

Area of Science:

  • Pediatric Pulmonology
  • Quality of Life Research
  • Chronic Lung Diseases

Background:

  • Bronchiolitis obliterans (BO) is a severe obstructive lung disease.
  • BO in children commonly results from infections or hematopoietic stem cell transplantation (HSCT).
  • Understanding the impact of BO on children's quality of life is crucial for management.

Purpose of the Study:

  • To compare the health-related quality of life (HRQOL) of children with BO to that of healthy children.
  • To investigate how the etiology of BO (post-infectious vs. post-HSCT) affects HRQOL.

Main Methods:

  • A cohort of children with BO (post-infectious and post-HSCT) and healthy controls were assessed.
  • Health-related quality of life was measured using the Short Form-36 (SF-36) and St George's Respiratory Questionnaire (SGRQ).
  • Correlations between clinical factors, pulmonary function, imaging, and HRQOL were analyzed.

Main Results:

  • Children with BO demonstrated significantly lower SF-36 scores compared to healthy children.
  • Post-HSCT BO patients exhibited poorer HRQOL in physical and social functioning compared to post-infectious BO.
  • Poorer lung function and increased healthcare utilization (therapies, exacerbations, hospitalizations) correlated with lower HRQOL.

Conclusions:

  • Children with BO experience a diminished HRQOL, particularly those following HSCT.
  • HRQOL assessment is essential for comprehensive care and management strategies in pediatric chronic lung diseases like BO.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
629
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K